FIIO's vacuum tube integrated amplifier, the "EA13," will be released on October 9th. This is a memo to help me decide whether to place this amplifier, which is expected to cost around 132,000 yen, in ...
In this discussion, Heather Burrell-Ward, M.D., provides an overview of her recent study that found TMS aimed at the default mode network improved processing speed in schizophrenia.
Presenter: Professor Lung-Yi Loey Mak, MBBS (HK), MD (HK), MRCP ( UK ), PDipID (HK), FHKCP, FHKAM (Medicine), FRCP (Glasg), FRCP (Edin), FRCP, Clinical Assistant Professor at The University of Hong ...
FleishmanHillard and Contagious today released a new study, "The Chaos Advantage," examining how the world's most successful ...
Genmab posted the biggest gain on the Stoxx Europe 600 in the first exchanges, up 7.87% at 2,564 DKK. The Danish drugmaker's ...
Galectin Therapeutics and its associated logo is a registered trademark of Galectin Therapeutics Inc. Belapectin is the USAN assigned name for Galectin Therapeutics’ galectin-3 inhibitor belapectin.
Monte Rosa Therapeutics (NASDAQ:GLUE) reported results from GFORCE-1, a Phase I study of its NEK7-directed molecular glue ...
F2G Ltd. today announced abstracts accepted for oral and poster presentation at IDWeek 2026, taking place October 212 ...
First clinical data for CPV-104 in patients, including interim safety, tolerability and pharmacokinetics, accepted as a ...
Risumaru, currently challenging the Management Business Chief exam!This time, I'm stepping away from the Civil Code I've been ...
Investing.com - European equities continued their recovery on Tuesday, attempting to build a floor after a violent global bond rout and French fiscal shocks severely disrupted the opening sessions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results